Ricerc@Sapienza

In treating head and neck cancer (HNC), the objectives are provided for best functional results and minimal risk of serious complications. The choice of appropriate management depends primarily on specific site and stage of primary tumor at diagnosis. Radiation therapy (RT) with or without concomitant chemotherapy represents a classical treatment option. In this review, we provide an update of recent research strategies to counteract the existing damage caused by RT and highlight clinical trials currently in progress.

Asthma is one of the most common chronic diseases of childhood. Fortunately, most children with asthma have a mild or moderate form of the disease [1], and symptom control can be achieved by ensuring adequate provision of care and continuously addressing the basics in asthma management through shared decision-making with patients and their families. However, asthma remains difficult to treat for a small proportion of children who may be symptomatic despite aggressive maintenance therapy and after management issues like adherence to treatment have been addressed [2, 3].